EPIX Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics through the use of its proprietary silico drug discovery platform.
Pulmonary Disease
Alkermes focuses on therapies for widespread, chronic diseases, such as central nervous system disorders, addiction, diabetes and autoimmune disorders, where we feel we have the opportunity to make the greatest impact.
Acusphere is a specialty pharmaceutical company that develops new drugs using our core proprietary microsphere technology. Our technology may be applied to drug targets in a wide variety of clinical applications and disease areas offering potentially significant benefits such as improved safety, efficacy, patient compliance, ease of use, expanded indications or reduced cost. Our current product candidates are designed to advance medical management within cardiology, oncology and pulmonary disease through use of flexible and targeted delivery systems.